Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study.

Tatur, Jacek; Lipinski, Michal; Sznurkowska, Marta; Józefik, Ewa; Rydzewska, Grazyna

Tatur, Jacek; Lipinski, Michal; Sznurkowska, Marta; Józefik, Ewa; Rydzewska, Grazyna.

Afiliación

Tatur J; Department of Gastroenterology, Central Clinical Hospital of The Ministry of Interior and Administration, Warsaw, Poland.
Lipinski M; Department of Gastroenterology, Central Clinical Hospital of The Ministry of Interior and Administration, Warsaw, Poland.
Sznurkowska M; Department of Gastroenterology, Central Clinical Hospital of The Ministry of Interior and Administration, Warsaw, Poland.
Józefik E; Collegium Medicum, Jan Kochanowski University of Kielce, Poland.
Rydzewska G; Department of Gastroenterology, Central Clinical Hospital of The Ministry of Interior and Administration, Warsaw, Poland.

Adv Clin Exp Med ; 31(4): 399-405, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35467085

Asunto(s)

Microbioma Gastrointestinal; Pancreatitis; Enfermedad Aguda; Humanos; Persona de Mediana Edad; Pancreatitis/tratamiento farmacológico; Estudios Retrospectivos; Rifaximina/uso terapéutico; Índice de Severidad de la Enfermedad

Palabras clave

acute pancreatitis therapy; gut decontamination; rifaximin treatment; selective digestive decontamination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pancreatitis / Microbioma Gastrointestinal Tipo de estudio: Observational_studies Límite: Humans / Middle aged Idioma: En Revista: Adv Clin Exp Med Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google